Prestige Consumer Healthcare Inc. ·
PBH 8-K 2026-11-05
Prestige Consumer Healthcare Inc. (PBH) 8-K dated 2026-11-05 — accession 0001295947-26-000055.
Prestige Consumer Healthcare Inc. (PBH) is a drug manufacturers - specialty & generic company listed on US.
Prestige Consumer Healthcare Inc. filed a 8-K on 2026-11-05. Accession 0001295947-26-000055.
This 8-K covers: Results of operations (Item 2.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported PBH revenue for 2026-03-31 was $1.09B. Net income was $190.3M. Revenue was down 4.3% from 2025-03-31 to 2026-03-31. PBH currently screens at market cap $4.00B.
Not investment advice. The PBH SEC hub lists recent forms. The stock page is the research view.